RAD December 2022 Abstracts and Posters

All accepted abstracts have been published in The British Journal of Dermatology, Volume 188, Issue Supplement 2, February 2023. You may access the publication at: https://academic.oup.com/bjd/issue/188/Supplement_2

#326 - Dupilumab: A Comparison of Infection Rates across Atopic Dermatitis Trials in Adults, Adolescents, Children, and Infants

Peter Lio, Lisa A. Beck, Vivian Y. Shi, Zhen Chen, Faisal A. Khokhar, Sonya L. Cyr, Tayler Gonzalez


#327 - Optimizing the management of atopic dermatitis with a new minimal disease activity concept and criteria and consensus-based recommendations for systemic therapy

Jonathan I. Silverberg, Melinda Gooderham, Norito Katoh, Valeria Aoki, Andrew E. Pink5, Yousef Binamer, Andreas Wollenberg


#328 - Understanding the impact of atopic dermatitis on patients: A large international, ethnically diverse survey-based qualitative study

Andreas Wollenberg, Melinda Gooderham, Norito Katoh, Valeria Aoki, Andrew E. Pink6, Yousef Binamer, Jonathan I. Silverberg


#329 - Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis

Amy S. Paller, Andreas Pinter, Lara Wine Lee, Roland Aschoff, Jacek Zdybski, Christina Schnopp, Amy Praestgaard, Ashish Bansal, Brad Shumel, Randy Prescilla, Mike Bastian


#330 - Safety of Abrocitinib in 3582 Patients With Moderate-to-Severe Atopic Dermatitis With Over 900 Patients Exposed for Almost 2 Years

Eric L. Simpson, Jonathan I. Silverberg, Audrey Nosbaum, Kevin Winthrop, Emma Guttman-Yassky, Karin M. Hoffmeister, Alexander Egeberg, Hernan Valdez, Haiyun Fan, Saleem A. Farooqui, Gary Chan, Justine Alderfer, William Romero, Susan Johnson


#331 - Prior Treatment Usage in Patients with Atopic Dermatitis Initiating Dupilumab: an Update from the GLOBOSTAD Registry

Silvia M. Ferrucci, Mariateresa Rossi, Daria S. Fomina, Hilde Lapeere, Wen-Hung Chung, Thrasyvoulos Tzellos, Anne-Claire Fougerousse, Jiangming Wu, Kwinten Bosman, Marius Ardeleanu


#332 - Improvement in symptoms of atopic dermatitis (AD) and AD-related quality of life with dupilumab treatment in adults: 24-week results of the DUPISTAD study

Joseph F. Merola, Albert S. Chiou, Emmanuel During, Antonio Costanzo, Peter Foley, Marius Ardeleanu, Jiangming Wu, Zafer E. Ozturk


#334 - Baseline Demographics and Family Disease History in Patients with Atopic Dermatitis: an Update from the GLOBOSTAD Registry

Piergiacomo Calzavara-Pinton, Jarmila Čelakovská, Hilde Lapeere, Gregor Holzer, Mona Al-Ahmad, Chia-Yu Chu, Jiangming Wu, Marius Ardeleanu, Kwinten Bosman


#335 - Improvement in sleep quality, anxiety, and depression in adults with moderate-to-severe atopic dermatitis with dupilumab treatment

Joseph F. Merola, Albert S. Chiou, Emmanuel During, Antonio Costanzo, Peter Foley, Marius Ardeleanu, Jiangming Wu, Zafer E. Ozturk


#336 - Efficacy Of Dupilumab In Infants And Preschoolers With Atopic Dermatitis Up To 1 Year

Amy S. Paller, Elaine C. Siegfried, Jing Xiao, Randy Prescilla, Ashish Bansal


Page 3 of 5
Results 21 - 30 of 50
© 2023 The Foundation for Dermatology Education.
The Foundation for Dermatology Education is a registered 501(c)(3) nonprofit organization located in Chicago, IL.